Bevacizumab/Carboplatin/Docetaxel Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of bevacizumab, carboplatin and docetaxel that can be used in the treatment of non-small cell lung cancer (NSCLC), and ovarian, fallopian tube and primary peritoneal cancers.

**Synonyms:** - Avastin/Carboplatin/Docetaxel - Bevacizumab-Carboplatin-Docetaxel - Bevacizumab/Carboplatin/Docetaxel - Carboplatin and Docetaxel (DCb) and Bevacizumab - Carboplatin and Docetaxel (DCb) and Bevacizumab-adcd - Carboplatin and Docetaxel (DCb) and Bevacizumab-awwb - Carboplatin and Docetaxel (DCb) and Bevacizumab-aybi - Carboplatin and Docetaxel (DCb) and Bevacizumab-bvzr - Carboplatin and Docetaxel (DCb) and Bevacizumab-equi - Carboplatin and Docetaxel (DCb) and Bevacizumab-maly - Carboplatin and Docetaxel (DCb) and Bevacizumab-onbe - Carboplatin and Docetaxel (DCb) and Bevacizumab-tnjn - Carboplatin/Bevacizumab/Docetaxel - Carboplatin/Docetaxel/Bevacizumab - Docetaxel/Bevacizumab/Carboplatin - Docetaxel/Carboplatin/Bevacizumab